80 related articles for article (PubMed ID: 1705827)
21. [The character of quantitative changes in some parameters of polyamine metabolism of the blood in patients with chronic leukemia].
Voronchikhina LD; Dem'ianova VT; Berdinskikh NK; Kolupaeva NV; Beznosikova TP
Vopr Med Khim; 1989; 35(1):74-7. PubMed ID: 2500778
[TBL] [Abstract][Full Text] [Related]
22. The effect of 5-aminolevulinic acid-based photodynamic treatment (PDT) on nucleoli of leukemic granulocytic precursors represented by K562 blastic cells in vitro.
Smetana K; Pluskalová M; Marinov Y; Hrkal Z
Med Sci Monit; 2004 Nov; 10(11):BR405-9. PubMed ID: 15507844
[TBL] [Abstract][Full Text] [Related]
23. Telomerase activity and telomere length in acute and chronic leukemia, pre- and post-ex vivo culture.
Engelhardt M; Mackenzie K; Drullinsky P; Silver RT; Moore MA
Cancer Res; 2000 Feb; 60(3):610-7. PubMed ID: 10676644
[TBL] [Abstract][Full Text] [Related]
24. Argyrophilic nucleolar organizer regions (AgNORs) in relation to p53 and bcl-2 protein expression in leukemia patients.
Klobusická M; Kusenda J; Babusíková O
Neoplasma; 2003; 50(6):408-15. PubMed ID: 14689061
[TBL] [Abstract][Full Text] [Related]
25. [Biochemical studies of the supernatant of leukemia cell cultures].
Kiersnowska-Rogowska B
Rocz Akad Med Im Juliana Marchlewskiego Bialymst; 1984-1985; 29-30():21-52. PubMed ID: 6101032
[No Abstract] [Full Text] [Related]
26. [Chronic lymphocytic and myeloid leukemia in the same patient].
Gregersen H; Drewes AM; Asschenfeldt PB; Laursen JC
Ugeskr Laeger; 1995 Nov; 157(45):6274-5. PubMed ID: 7491723
[TBL] [Abstract][Full Text] [Related]
27. 5-Fluorouracil-resistant CD34+ cell population from peripheral blood of CML patients contains BCR-ABL-negative progenitor cells.
Jazwiec B; Mahon FX; Pigneux A; Pigeonnier V; Reiffers J
Exp Hematol; 1995 Dec; 23(14):1509-14. PubMed ID: 8542939
[TBL] [Abstract][Full Text] [Related]
28. Interferon-alpha-treated patients with chronic myelogenous leukemia show BCR/ABL-positive peripheral blood progenitor cells surviving long-term culture.
Schultheis B; Heissig B; Pasternak G; Hörner S; Hehlmann R
Folia Biol (Praha); 2000; 46(6):251-5. PubMed ID: 11140858
[TBL] [Abstract][Full Text] [Related]
29. [Update on malignant hematologic diseases].
Marie JP; Delmer A
Bull Cancer; 1998 Jan; 85(1):42-4. PubMed ID: 9752345
[No Abstract] [Full Text] [Related]
30. Nucleolar silver-staining patterns related to cell cycle phase and cell generation of PHA-stimulated human lymphocytes.
Field DH; Fitzgerald PH; Sin FY
Cytobios; 1984; 41(161):23-33. PubMed ID: 6084580
[TBL] [Abstract][Full Text] [Related]
31. Biological characterization of stem cell present in mobilized peripheral blood of CML patients.
Tsukamoto AS; Reading C; Carella A; Frassoni F; Gorin C; LaPorte J; Negrin R; Blume K; Cunningham I; Deisseroth A
Bone Marrow Transplant; 1994; 14 Suppl 3():S25-32. PubMed ID: 7535151
[TBL] [Abstract][Full Text] [Related]
32. Collection of 'normal' blood repopulating cells during early hemopoietic recovery after intensive conventional chemotherapy in chronic myelogenous leukemia.
Carella AM; Podesta M; Frassoni F; Raffo MR; Pollicardo N; Pungolino E; Vimercati R; Sessarego M; Parodi C; Rabitti C
Bone Marrow Transplant; 1993 Sep; 12(3):267-71. PubMed ID: 7694724
[TBL] [Abstract][Full Text] [Related]
33. The INK4-ARF (CDKN2A/B) locus in hematopoiesis and BCR-ABL-induced leukemias.
Williams RT; Sherr CJ
Cold Spring Harb Symp Quant Biol; 2008; 73():461-7. PubMed ID: 19028987
[TBL] [Abstract][Full Text] [Related]
34. Use of granulocyte-macrophage colony-stimulating factor (GM-CSF) in combination with hydroxyurea as post-transplant therapy in chronic myelogenous leukemia patients autografted with unmanipulated hematopoietic cells.
Carlo-Stella C; Regazzi E; Andrizzi C; Savoldo B; Garau D; Montefusco E; Vignetti M; Mandelli F; Rizzoli V; Meloni G
Haematologica; 1997; 82(3):291-6. PubMed ID: 9234574
[TBL] [Abstract][Full Text] [Related]
35. Ubiquitous expression of cytokines in diverse leukemias of lymphoid and myeloid lineage.
Kurzrock R; Kantarjian H; Wetzler M; Estrov Z; Estey E; Troutman-Worden K; Gutterman JU; Talpaz M
Exp Hematol; 1993 Jan; 21(1):80-5. PubMed ID: 8417962
[TBL] [Abstract][Full Text] [Related]
36. Mean diameter of nucleolar bodies in cultured human leukemic myeloblasts is mainly related to the S and G2 phase of the cell cycle.
Smetana K; Kuzelova K; Zápotocký M; Starková J; Hrkal Z; Trka J
Eur J Histochem; 2007; 51(4):269-74. PubMed ID: 18162456
[TBL] [Abstract][Full Text] [Related]
37. Colony growth in cultures from bone marrow and peripheral blood after curative treatment for leukemia and severe aplastic anemia.
Betticher DC; Huxol H; Müller R; Speck B; Nissen C
Exp Hematol; 1993 Nov; 21(12):1517-21. PubMed ID: 8405233
[TBL] [Abstract][Full Text] [Related]
38. L-selectin expression is low on CD34+ cells from patients with chronic myeloid leukemia and interferon-a up-regulates this expression.
Martín-Henao GA; Quiroga R; Sureda A; González JR; Moreno V; García J
Haematologica; 2000 Feb; 85(2):139-46. PubMed ID: 10681720
[TBL] [Abstract][Full Text] [Related]
39. In vitro thymidine uptake by circulating leukocytes.
Sokal JE; Pauly JL
J Lab Clin Med; 1974 Nov; 84(5):681-91. PubMed ID: 4283790
[No Abstract] [Full Text] [Related]
40. Autocrine and paracrine effects of an ES-cell derived, BCR/ABL-transformed hematopoietic cell line that induces leukemia in mice.
Peters DG; Klucher KM; Perlingeiro RC; Dessain SK; Koh EY; Daley GQ
Oncogene; 2001 May; 20(21):2636-46. PubMed ID: 11420675
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
